Predictive value of age combined with albumin-bilirubin score for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

ZHANG Wenjing; GAN Jianhe

doi:10.7619/jcmp.20233228

Journal of Clinical Medicine in Practice > 2024 > 28(5): 53-58. > DOI: 10.7619/jcmp.20233228

ZHANG Wenjing, GAN Jianhe. Predictive value of age combined with albumin-bilirubin score for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Medicine in Practice, 2024, 28(5): 53-58. DOI: 10.7619/jcmp.20233228

Citation:

PDF (964 KB)

Predictive value of age combined with albumin-bilirubin score for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

ZHANG Wenjing,
GAN Jianhe^,

Department of Infection, the First Hospital Affiliated to Soochow University, Suzhou, Jiangsu, 215000

More Information

Received Date: October 10, 2023
Revised Date: December 05, 2023
Available Online: March 21, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the predictive value of age combined with albumin-bilirubin (ALBI) score for the occurrence of overt hepatic encephalopathy (OHE) in patients with cirrhosis complicated by esophageal and gastric variceal bleeding (EGVB) after transjugular intrahepatic portosystemic shunt (TIPS).
Methods
A retrospective analysis was performed on the clinical data of 87 patients with cirrhosis complicated by EGVB who underwent TIPS. The patients were followed up for 6 months, and were divided into OHE group (27 cases) and non-OHE group (60 cases) based on whether OHE occurred. The indicators with significant differences between the two groups were screened out through univariate analysis, and binary Logistic regression analysis was performed to identify the independent risk factors for OHE occurrence. The receiver operating characteristic (ROC) curve was plotted to evaluate the predictive performance of the individual and combined independent risk factors for OHE. The differences in area under the curve (AUC) were compared using MedCalc software.
Results
Among 87 patients, 27 developed OHE within 6 months after surgery, with a prevalence rate of 31.03%. Univariate analysis showed that there were significant differences in age, albumin, serum sodium, and ALBI score between the OHE group and the non-OHE group (P < 0.05). Binary Logistic regression analysis showed that age (OR=1.08; 95%CI, 1.02 to 1.14; P=0.01) and ALBI score (OR=13.68; 95%CI, 3.00 to 62.44; P < 0.01) were independent risk factors for OHE in patients with cirrhosis complicated by EGVB after TIPS. ROC curve analysis showed that the AUC for age and ALBI score in predicting OHE were 0.67 (95%CI, 0.55 to 0.79; P=0.01)and 0.72 (95%CI, 0.60 to 0.85; P < 0.01), respectively; the AUC for age combined with ALBI score in predicting OHE was 0.80 (95%CI, 0.70 to 0.91; P < 0.01), with a sensitivity of 77.8% and a specificity of 75.0%. There was no significant difference in the AUC by age and ALBI score alone in predicting OHE (P>0.05); however, the AUC for age combined with ALBI score in predicting OHE was greater than that of age or ALBI score alone in predicting OHE, and the difference was statistically significant (P < 0.05).
Conclusion
Age and ALBI score are independent risk factors for the occurrence of OHE in patients with cirrhosis complicated by EGVB after TIPS. The combination of age and ALBI score has a higher predictive efficacy in predicting OHE than age or ALBI score alone.
- age,
- albumin-bilirubin score,
- cirrhosis,
- transjugular intrahepatic portosystemic shunt,
- overt hepatic encephalopathy

FullText(HTML)

References (25)

References

[1]	TSOCHATZIS E A, BOSCH J, BURROUGHS A K. Liver cirrhosis[J]. Lancet, 2014, 383(9930): 1749-1761. doi: 10.1016/S0140-6736(14)60121-5
[2]	LEE H L, LEE S W. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: advantages and pitfalls[J]. Clin Mol Hepatol, 2022, 28(2): 121-134. doi: 10.3350/cmh.2021.0239
[3]	HORHAT A, BUREAU C, THABUT D, et al. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: indications and posttransjugular intrahepatic portosystemic shunt complications in 2020[J]. United European Gastroenterol J, 2021, 9(2): 203-208. doi: 10.1177/2050640620952637
[4]	PEREIRA K, CARRION A F, MARTIN P, et al. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy[J]. Liver Int, 2015, 35(12): 2487-2494. doi: 10.1111/liv.12956
[5]	CORONADO W M, JU C, BULLEN J, et al. Predictors of occurrence and risk of hepatic encephalopathy after TIPS creation: a 15-year experience[J]. Cardiovasc Intervent Radiol, 2020, 43(8): 1156-1164. doi: 10.1007/s00270-020-02512-7
[6]	SCHINDLER P, HEINZOW H, TREBICKA J, et al. Shunt-induced hepatic encephalopathy in TIPS: current approaches and clinical challenges[J]. J Clin Med, 2020, 9(11): 3784. doi: 10.3390/jcm9113784
[7]	JOHNSON P J, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6): 550-558. doi: 10.1200/JCO.2014.57.9151
[8]	WANG J, ZHANG Z P, YAN X M, et al. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis[J]. Dig Liver Dis, 2019, 51(8): 1172-1178. doi: 10.1016/j.dld.2019.01.011
[9]	FUJITA K, OURA K, YONEYAMA H, et al. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C[J]. Hepatol Res, 2019, 49(7): 731-742. doi: 10.1111/hepr.13333
[10]	CALZADILLA-BERTOT L, VILAR-GOMEZ E, WONG V W S, et al. ABIDE: an accurate predictive model of liver decompensation in patients with nonalcoholic fatty liver-related cirrhosis[J]. Hepatology, 2021, 73(6): 2238-2250. doi: 10.1002/hep.31576
[11]	中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2023, 39(3): 527-538. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD202303008.htm
[12]	中华医学会消化病学分会微创介入协作组. 经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识(2022年版)[J]. 中华肝脏病杂志, 2022, 30(12): 1349-1364. doi: 10.3760/cma.j.cn501113-20221109-00553
[13]	徐小元, 丁惠国, 李文刚, 等. 肝硬化肝性脑病诊疗指南(2018年, 北京)[J]. 中华胃肠内镜电子杂志, 2018, 5(3): 97-113. https://www.cnki.com.cn/Article/CJFDTOTAL-WCNJ201803001.htm
[14]	YANG Y, LIANG X Q, YANG S R, et al. Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt[J]. Eur J Radiol, 2022, 154: 110384. doi: 10.1016/j.ejrad.2022.110384
[15]	SHARMA B C, MAHARSHI S. Prevention of hepatic encephalopathy recurrence[J]. Clin Liver Dis, 2015, 5(3): 64-67. doi: 10.1002/cld.446
[16]	GAZDA J, COLA S D, LAPENNA L, et al. The impact of transjugular intrahepatic portosystemic shunt on nutrition in liver cirrhosis patients: a systematic review[J]. Nutrients, 2023, 15(7): 1617. doi: 10.3390/nu15071617
[17]	PRAKTIKNJO M, ABU-OMAR J, CHANG J, et al. Controlled underdilation using novel VIATORR? controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation[J]. JHEP Rep, 2021, 3(3): 100264. doi: 10.1016/j.jhepr.2021.100264
[18]	CASADABAN L C, PARVINIAN A, MINOCHA J, et al. Clearing the confusion over hepatic encephalopathy after TIPS creation: incidence, prognostic factors, and clinical outcomes[J]. Dig Dis Sci, 2015, 60(4): 1059-1066. doi: 10.1007/s10620-014-3391-0
[19]	DENG M, NG S W Y, CHEUNG S T, et al. Clinical application of Albumin-Bilirubin (ALBI) score: the current status[J]. Surgeon, 2020, 18(3): 178-186. doi: 10.1016/j.surge.2019.09.002
[20]	KIM H J, LEE H W. Important predictor of mortality in patients with end-stage liver disease[J]. Clin Mol Hepatol, 2013, 19(2): 105-115. doi: 10.3350/cmh.2013.19.2.105
[21]	ZOU D L, QI X S, ZHU C H, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study[J]. Turk J Gastroenterol, 2016, 27(2): 180-186. doi: 10.5152/tjg.2016.15502
[22]	RONALD J, WANG Q, CHOI S S, et al. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation[J]. Diagn Interv Imaging, 2018, 99(3): 163-168. doi: 10.1016/j.diii.2017.10.008
[23]	LIN X R, GAO F, WU X X, et al. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt[J]. Eur J Gastroenterol Hepatol, 2021, 33(6): 862-871. doi: 10.1097/MEG.0000000000001801
[24]	李朝先. 前白蛋白、ALBI、CONUT评分对肝硬化EGVB患者TIPS术后肝性脑病的预测价值评估[D]. 昆明: 昆明医科大学, 2022.
[25]	FONIO P, DISCALZI A, CALANDRI M, et al. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification[J]. Radiol Med, 2017, 122(9): 713-721. doi: 10.1007/s11547-017-0770-6

[1]	KANG Lin, ZHU Ying, GAO Yun, HUANG Jin, LI Runjie. Relationship of serum calcitonin, brain natriuretic peptide and cardiac troponin I with disease severity of senile pneumonia[J]. Journal of Clinical Medicine in Practice, 2023, 27(17): 93-96. DOI: 10.7619/jcmp.20231133
[2]	LI Yuanyuan, CHEN Biquan, XIE Qilian. Role of zinc preparations in improving myocardial enzymes and cardiac troponin I of children with pediatric rotavirus enteritis[J]. Journal of Clinical Medicine in Practice, 2023, 27(11): 85-88. DOI: 10.7619/jcmp.20230373
[3]	REN Mingrong, ZHANG Yong, TAN Qin, TAN Jingyu, SU Jing, LI Yongxia, YUAN Li. Correlation of serum uric acid and fasting blood glucose with elasticity of large artery[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 54-57. DOI: 10.7619/jcmp.20212613
[4]	PENG Lingling, DUAN Yu. Correlation between serum uric acid and glomerular filtration rate in people with physical examination[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 102-106. DOI: 10.7619/jcmp.20213570
[5]	YANG Lin, WANG Yixiong. Correlation between change of blood uric acid, serum calcium and plasma albumin during pregnancy and collaborative forecasting of preeclampsia[J]. Journal of Clinical Medicine in Practice, 2018, (7): 70-73. DOI: 10.7619/jcmp.201807019
[6]	GE Chao, CUI Liufu, YANG Wenhao. The influence of serum uric acid on patients with coronary heart disease and its nursing intervention[J]. Journal of Clinical Medicine in Practice, 2016, (18): 7-10. DOI: 10.7619/jcmp.201618003
[7]	JIN Guoxian, JIN Shuo, CHEN Gang, SHAO Lichun. Clinical significance of changes in levels of plasma pro B natriuretic peptide and serum cardiac troponin Ⅰ in patient with cirrhosis[J]. Journal of Clinical Medicine in Practice, 2015, (7): 41-43. DOI: 10.7619/jcmp.201507011
[8]	ZHOU Weihong. Effect of valsartan combined with amlodipine on the level of blood sugar,serum lipid and blood uric acid of elderly patients with hypertension complicated with diabetics[J]. Journal of Clinical Medicine in Practice, 2014, (15): 14-16. DOI: 10.7619/jcmp.201415005
[9]	SHEN Yating, FANG Zhirong, ZHU Chunlei. Correlation between carotid artery atherosclerosis and blood uric acid level in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2013, (21): 16-18. DOI: 10.7619/jcmp.201321005
[10]	ZHANG Ya-ting. Changes of blood lipids, blood sugar and serum uric acid in patients with subclinical hypothyroidism[J]. Journal of Clinical Medicine in Practice, 2012, (13): 100-101,104. DOI: 10.3969/j.issn.1672-2353.2012.13.036

Cited By

Get Citation

PDF

XML

Article views (116) PDF downloads (9)

Turn off MathJax

Article Contents

Abstract

References

Predictive value of age combined with albumin-bilirubin score for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

Abstract

References

Related Articles

Catalog

Predictive value of age combined with albumin-bilirubin score for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

Abstract

References

Related Articles

Catalog

Export File

Citation

Format

Content